Enhabit (EHAB) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US29332G1022

Enhabit, Inc., traded as EHAB on the NYSE, is a leading provider of home health and hospice services in the United States.
Its comprehensive home health services encompass patient education, pain management, wound care, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services. Enhabit also specializes in treating chronic diseases such as diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care, and chronic pain. Additionally, the company's disease-specific plans cater to patients with diabetes, congestive heart failure, post-orthopedic surgery, injury, and respiratory diseases. Enhabit's team of physical, occupational, and speech therapists offer top-notch therapy services.

Enhabit extends its services to hospice care, offering pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services. Their hospice services are designed to address the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families.

Operating across 23 states, Enhabit, Inc. has a robust presence with 252 home health agencies and 105 hospice agencies as of December 31, 2022. Formerly known as Encompass Health Home Health Holdings, Inc., the company rebranded to Enhabit, Inc. in March 2022. Established in 2014, Enhabit, Inc. is headquartered in Dallas, Texas. For more information, visit their website at https://www.ehab.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Enhabit (EHAB) - Stock Price & Dividends

EHAB Stock Overview

Market Cap in USD 501m
Sector Healthcare
Industry Medical Care Facilities
GiC SubIndustry Health Care Services
TER 0.00%
IPO / Inception 2022-07-01

EHAB Stock Ratings

Growth 5y -4.70
Fundamental -39.0
Dividend -
Rel. Performance vs Sector -3.91
Analysts 3.00/5
Fair Price Momentum 8.11 USD
Fair Price DCF 8.98 USD

EHAB Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

EHAB Growth Ratios

Growth 12m -21.33%
Growth Correlation 12m -38%
Growth Correlation 3m 20%
CAGR 5y -39.56%
Sharpe Ratio 12m -0.44
Alpha vs SP500 12m -38.31
Beta vs SP500 5y weekly 0.54
ValueRay RSI 25.28
Volatility GJR Garch 1y 52.34%
Price / SMA 50 -6.19%
Price / SMA 200 -7.62%
Current Volume 370k
Average Volume 20d 319.2k

External Links for EHAB Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
X (Twitter)Stocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of EHAB stocks?
As of May 09, 2024, the stock is trading at USD 9.70 with a total of 370,003 shares traded.
Over the past week, the price has changed by -4.72%, over one month by -12.38%, over three months by +8.99% and over the past year by -28.09%.
What is the forecast for EHAB stock price target?
According to ValueRays Forecast Model, EHAB Enhabit will be worth about 8.8 in May 2025. The stock is currently trading at 9.70. This means that the stock has a potential downside of -9.79%.
Issuer Forecast Upside
Wallstreet Target Price 10.9 12.7
Analysts Target Price 11.1 14.2
ValueRay Target Price 8.8 -9.79